Cowa LLC Has $276,000 Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Cowa LLC cut its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 26.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,778 shares of the pharmacy operator’s stock after selling 3,168 shares during the period. Cowa LLC’s holdings in Walgreens Boots Alliance were worth $276,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the company. Bank of New Hampshire boosted its stake in Walgreens Boots Alliance by 56.4% during the 3rd quarter. Bank of New Hampshire now owns 960 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 346 shares during the last quarter. WFA of San Diego LLC acquired a new position in Walgreens Boots Alliance during the 2nd quarter valued at about $32,000. Baystate Wealth Management LLC boosted its stake in Walgreens Boots Alliance by 209.4% during the 2nd quarter. Baystate Wealth Management LLC now owns 1,216 shares of the pharmacy operator’s stock valued at $46,000 after purchasing an additional 823 shares during the last quarter. Ronald Blue Trust Inc. acquired a new position in Walgreens Boots Alliance during the 2nd quarter valued at about $46,000. Finally, CX Institutional acquired a new position in Walgreens Boots Alliance during the 2nd quarter valued at about $47,000. 56.71% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Director Nancy M. Schlichting sold 16,570 shares of the business’s stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $39.89, for a total transaction of $660,977.30. Following the sale, the director now owns 5,515 shares of the company’s stock, valued at approximately $219,993.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Walgreens Boots Alliance news, EVP Kevin M. Ban sold 10,303 shares of the firm’s stock in a transaction dated Friday, November 18th. The stock was sold at an average price of $40.19, for a total value of $414,077.57. Following the sale, the executive vice president now owns 27,916 shares of the company’s stock, valued at approximately $1,121,944.04. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Nancy M. Schlichting sold 16,570 shares of the firm’s stock in a transaction dated Thursday, November 17th. The shares were sold at an average price of $39.89, for a total value of $660,977.30. Following the completion of the sale, the director now directly owns 5,515 shares in the company, valued at approximately $219,993.35. The disclosure for this sale can be found here. Insiders own 17.40% of the company’s stock.

Analyst Ratings Changes

WBA has been the topic of a number of research analyst reports. Mizuho boosted their target price on Walgreens Boots Alliance from $36.00 to $41.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 14th. Credit Suisse Group cut their target price on Walgreens Boots Alliance from $42.00 to $41.00 and set a “neutral” rating on the stock in a research note on Friday, January 6th. Evercore ISI cut their target price on Walgreens Boots Alliance from $41.00 to $32.00 and set an “in-line” rating on the stock in a research note on Monday, October 3rd. Deutsche Bank Aktiengesellschaft upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and boosted their target price for the stock from $41.00 to $50.00 in a research note on Friday, November 11th. Finally, Truist Financial cut their target price on Walgreens Boots Alliance from $44.00 to $42.00 and set a “hold” rating on the stock in a research note on Thursday, January 19th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus target price of $43.46.

Walgreens Boots Alliance Trading Down 0.4 %

NASDAQ:WBA opened at $35.75 on Wednesday. The company has a current ratio of 0.70, a quick ratio of 0.36 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $30.83 billion, a PE ratio of -10.44, a price-to-earnings-growth ratio of 1.63 and a beta of 0.75. The firm’s 50 day moving average is $38.86 and its 200 day moving average is $37.22. Walgreens Boots Alliance, Inc. has a 12 month low of $30.39 and a 12 month high of $51.51.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last issued its earnings results on Thursday, January 5th. The pharmacy operator reported $1.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.15 by $0.01. Walgreens Boots Alliance had a negative net margin of 2.24% and a positive return on equity of 13.57%. The business had revenue of $33.38 billion for the quarter, compared to analysts’ expectations of $33.04 billion. During the same quarter in the previous year, the firm posted $1.68 EPS. The business’s revenue for the quarter was down 1.5% compared to the same quarter last year. Sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 4.5 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, December 12th. Shareholders of record on Tuesday, November 15th were issued a dividend of $0.48 per share. The ex-dividend date of this dividend was Monday, November 14th. This represents a $1.92 dividend on an annualized basis and a yield of 5.37%. Walgreens Boots Alliance’s payout ratio is -55.81%.

Walgreens Boots Alliance Company Profile

(Get Rating)

Walgreens Boots Alliance, Inc operates as an integrated healthcare, pharmacy, and retailer in the United States (U.S.), the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Further Reading

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.